Insilico Medicine Joins HKEX Tech 100 as AI Drug Discovery Gains Market Recognition
Generative AI is beginning to reshape not only how medicines are discovered, but also how investors classify the companies building that technology. Insilico Medicine will join the HKEX Tech 100 Index in September, placing the AI-driven drug discovery company alongside Hong Kong-listed businesses representing artificial intelligence, biotechnology, robotics and other technology themes. The boundary between…
